by Editorial Staff | Apr 6, 2023 | News Release
London, UK – 06 April 2023 – Sorbie Bornholm LP, (“Sorbie”) a UK Investment Fund, is pleased to announce a follow-on investment in Tocvan Ventures Corp. (“Tocvan”) (CSE: TOC; OTCQB: TCVNF; WKN: TV3/A2PE64). The gross amount of the investment is $600,000 (CAD). The...
by Editorial Staff | Jul 13, 2022 | News Release
London, UK – July 13, 2022 – Sorbie Bornholm LP, (“Sorbie”) a UK Investment Fund, is pleased to announce an investment in Bee Vectoring Technologies International Inc. (“BVT”) (CSE: BEE) (OTCQB: BEVVF) (CVE:BEE). The gross amount of the investment is $3.8...
by Editorial Staff | Jul 1, 2022 | News Release
London, UK – June 30, 2022 – Sorbie Bornholm LP, (“Sorbie”) a UK Investment Fund, is pleased to announce an investment in Tocvan Ventures Corp. (the “Company”) (CSE: TOC; OTCQB: TCVNF; WKN: TV3/A2PE64). The gross amount of the investment is $5.125 million...
by Editorial Staff | Mar 24, 2022 | News Release
London, UK – March 24, 2022 – Sorbie Bornholm, (“Sorbie”) a UK Investment Fund, is pleased to announce an investment in Sixth Wave Innovations, Inc., (CSE:SIXW) (OTCQB:SIXWF) (FSE:AHUH) (“Sixth Wave” or the “Company”) a nanotechnology company with patented...
by Editorial Staff | Nov 21, 2019 | News Release
Sorbie works with Kogi Iron for up to $4.35m Investment Kogi Iron Limited (ASX: KFE) (“Kogi”, “Kogi Iron” or the “Company”) and its 100% owned Nigerian operating company, KCM Mining Limited (“KCM”) are pleased to announce the following capital raisings: share...
by Editorial Staff | Jun 29, 2017 | News Release
Placement anchored by A$10 million from UK fund Neuren Pharmaceuticals (ASX:NEU) has secured a funding of A$11.5 million via the placement of shares at $0.062 each, to enable the initiation of key activities for commencing a Phase 3 trial in Rett syndrome. Neuren is...
